[go: up one dir, main page]

ES2118129T3 - Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos. - Google Patents

Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.

Info

Publication number
ES2118129T3
ES2118129T3 ES92906219T ES92906219T ES2118129T3 ES 2118129 T3 ES2118129 T3 ES 2118129T3 ES 92906219 T ES92906219 T ES 92906219T ES 92906219 T ES92906219 T ES 92906219T ES 2118129 T3 ES2118129 T3 ES 2118129T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
putative
procedures
antibodies against
cover regions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92906219T
Other languages
English (en)
Inventor
Mary S Gibadlo
Joan D Tyner
Larry T Mimms
David S Vallari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2118129T3 publication Critical patent/ES2118129T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

ANTICUERPOS MONOCLONALES QUE SE UNEN ESPECIFICAMENTE A LA REGION ENVOLVENTE DEL VIRUS DE LA HEPATITIS C PUTATIVO (HCV). TAMBIEN SE PRESENTAN LAS LINEAS CELULARES DE HIBRIDOMAS QUE SEGREGAN ESTOS ANTICUERPOS MONOCLONALES, LOS METODOS PARA LA UTILIZACION DE ESTOS ANTICUERPOS MONOCLONALES Y LOS KITS DE ENSAYO QUE CONTIENEN ESTOS ANTICUERPOS MONOCLONALES.
ES92906219T 1991-01-31 1992-01-30 Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos. Expired - Lifetime ES2118129T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64847591A 1991-01-31 1991-01-31

Publications (1)

Publication Number Publication Date
ES2118129T3 true ES2118129T3 (es) 1998-09-16

Family

ID=24600936

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92906219T Expired - Lifetime ES2118129T3 (es) 1991-01-31 1992-01-30 Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.

Country Status (10)

Country Link
EP (1) EP0569537B1 (es)
JP (1) JP3483555B2 (es)
KR (1) KR930703361A (es)
AT (1) ATE167522T1 (es)
AU (1) AU662517B2 (es)
CA (1) CA2101534C (es)
DE (1) DE69225960T2 (es)
DK (1) DK0569537T3 (es)
ES (1) ES2118129T3 (es)
WO (1) WO1992013892A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Polypeptide des hepatitis c-virus (hiv)
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
ES2174957T5 (es) * 1994-07-29 2006-12-16 Innogenetics N.V. Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
EP0947525A1 (en) * 1998-03-27 1999-10-06 Innogenetics N.V. Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
WO2001009609A2 (en) * 1999-07-28 2001-02-08 Chiron Corporation Hepatitis c viral antigen immunoassay detection systems
HRP20140316T1 (hr) 2007-02-21 2014-05-09 University Of Massachusetts Humana antitijela protiv virusa hepatitisa c (hcv) i njihova uporaba
US20100291545A1 (en) 2007-07-25 2010-11-18 Takaji Wakita Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof
US8993228B2 (en) 2008-09-30 2015-03-31 Toray Industries, Inc. Antibody binding to envelope protein 2 of hepatitis C virus and method for identifying genotype of hepatitis C virus using the same
WO2011052735A1 (ja) 2009-10-30 2011-05-05 東レ株式会社 C型肝炎ウイルス（hcv）に対して感染阻害活性を有する抗体及びその用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1168579A (en) * 1981-02-11 1984-06-05 Philippe Maupas (Deceased) Non-a, non-b hepatitis virus
HU216017B (hu) * 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
CA2079677A1 (en) * 1990-04-03 1991-10-04 Kenneth H. Burk Purified hcv and hcv proteins and peptides
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
ATE206717T1 (de) * 1990-11-03 2001-10-15 Dade Behring Marburg Gmbh Hcv-spezifische peptide, mittel dazu und ihre verwendung
ES2132115T3 (es) * 1990-11-07 1999-08-16 Abbott Lab Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.

Also Published As

Publication number Publication date
JP3483555B2 (ja) 2004-01-06
HK1012838A1 (en) 1999-08-06
KR930703361A (ko) 1993-11-29
EP0569537A4 (en) 1994-10-05
JPH06505389A (ja) 1994-06-23
WO1992013892A1 (en) 1992-08-20
EP0569537B1 (en) 1998-06-17
CA2101534C (en) 2004-01-20
EP0569537A1 (en) 1993-11-18
CA2101534A1 (en) 1992-08-01
DK0569537T3 (da) 1999-04-06
AU1362792A (en) 1992-09-07
AU662517B2 (en) 1995-09-07
DE69225960D1 (de) 1998-07-23
DE69225960T2 (de) 1999-01-21
ATE167522T1 (de) 1998-07-15

Similar Documents

Publication Publication Date Title
ES2139607T3 (es) Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos.
ATE171472T1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
ES2065863T3 (es) Analisis para la deteccion de virus de la hepatitis c.
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
ATE239756T1 (de) Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag)
DK0482176T3 (da) Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile
ES2118129T3 (es) Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.
ATE51876T1 (de) Monoklonale antikoerper gegen kernproteine von lymphadenopathie-assoziierten viren.
DE69932812D1 (de) Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe
ES2173910T3 (es) Anticuerpos humanizados dirigidos contra el antigeno a33.
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
EA200200974A1 (ru) Моноклональные антитела к рецептору лпнп человека, их получение и применение
ES2132115T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.
ES2126598T3 (es) Anticuerpos monoclonales que se fijan sobre las proteinas ns5 supuestas del virus de la hepatitis c, y procedimientos de utilizacion de estos anticuerpos.
ES2093135T3 (es) Anticuerpos monoclonales contra el complejo plasmina-antiplasmina, procedimiento para su preparacion asi como su utilizacion.
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
FI952779A7 (fi) HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
ATE100859T1 (de) Durch virusneutralisierende und schuetzende monokonale antikoerper erkanntes ibdv vp2 epitop.
ATE13446T1 (de) Monoklonaler antikoerper gegen menschliche zytotoxische und suppressor-t-zellen und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 569537

Country of ref document: ES